STEVEN YANG: Open Payments
NPI 1487204921 · WEST COVINA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 57 payments from 7 companies in 2025. Trend: 2023 $362 · 2024 $651 · 2025 $1,584
Food & beverage: $1,584
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $600 |
| Janssen Pharmaceuticals, Inc | 10 | $470 |
| E.R. Squibb & Sons, L.L.C. | 17 | $281 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| ABBVIE INC. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: ARISTADA, INVEGA SUSTENNA, COBENFY, LYBALVI, REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
